Adial Pharmaceuticals, Inc. has received notice from the U.S. Securities and Exchange Commission (SEC) regarding the effectiveness of its Form S-1 registration statement. The effectiveness date is set for December 30, 2024, at 4:00 P.M.The Form S-1, with file number 333-283968, was filed under the company's CIK number 0001513525. This registration statement typically indicates the company's intent to offer securities to the public, which could include an initial public offering (IPO) or a follow-on offering of shares.

Adial Pharmaceuticals, Inc. has received notice from the U.S. Securities and Exchange Commission (SEC) regarding the effectiveness of its Form S-1 registration statement. The effectiveness date is set for December 30, 2024, at 4:00 P.M.The Form S-1, with file number 333-283968, was filed under the company's CIK number 0001513525. This registration statement typically indicates the company's intent to offer securities to the public, which could include an initial public offering (IPO) or a follow-on offering of shares.